Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.89
- Piotroski Score 4.00
- Grade In-Line
- Symbol (BOLD)
- Company Boundless Bio, Inc. Common Stock
- Price $3.44
- Changes Percentage (1.47%)
- Change $0.05
- Day Low $3.28
- Day High $3.51
- Year High $15.24
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/27/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio N/A
- Forward P/E Ratio N/A
- P/E Growth N/A
- Net Income $-49,434,000
Income Statement
Quarterly
Annual
Latest News of BOLD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
The bold move that led Gunnar Henderson to Orioles stardom: 'We decided to skip six grades'
In June 2019, Gunnar Henderson was overlooked in the MLB draft. However, he defied expectations and became a top player for the Baltimore Orioles, showcasing resilience and talent, proving scouting mi...
By The New York Times | 19 hours ago -
China's factory, service sectors skid, emboldening stimulus calls
By Ellen Zhang, Ryan WooBEIJING (Reuters) -China's factory activity shrank for a fifth straight month and the services sector slowed sharply in September, suggesting Beijing will need even more stimul...
By Reuters | 1 day ago -
5 Bold Predictions For Week 4 of NFL Season
The NFL season is in full swing with exciting matchups and surprising performances. Newsweek Sports offers bold predictions for Week 4 games, including struggles for the Jaguars and Bears, an Eagles w...
By Newsweek | 1 day ago
